The effect of Duloxetine on shoulder pain of patients with myofascial pain syndrome who undergo arthroscopic rotator cuff repair or adhesive capsulitis patient with glenohumeral injection

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0004361

Enrollment

Registered

2019-10-21

Start date

2019-10-01

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : The subjects of this study were the patients with myofascial pain syndrome who were scheduled to undergo arthroscopic rotator cuff repair due to complete rotator cuff tear. The preoperative cen

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion Criteria ? Patients diagnosed with myofascial pain syndrome who are over 19 years old and younger than 70 years who underwent arthroscopic rotator cuff repair due to complete rotator cuff tear ? Patients with central sensitization (Central Sensitization Inventory (CSI) score of 40 or more) ? Patients who understand this study and agree to participate in the study

Exclusion criteria

Exclusion criteria: Exclusion Criteria ? Non-central sensitization patients (Central Sensitization Inventory (CSI) score below 40) ? Patients who have previously taken Duloxetine ? Patients with hypersensitivity or excessive complications after taking Duloxetine ? Patients diagnosed and treated for psychiatric disease ? Patients with local infection, sepsis, or previous neurological abnormalities ? Patients with uncontrolled hypertension who have more than 100mmHg of diastolic blood pressure ? Patients with abnormal liver function (aspartate aminotransferase or alanine aminotransferase> 60 IU litre) ? Patients with severe cardiovascular disease or kidney disorders

Design outcomes

Secondary

Measure	Time frame
Shoulder joint range of motion;Functional scores (ASES score, Constant score, KSES score);Mental component summary score of the Short Form-36 (SF-36) II, Hamilton depression scale	—

Primary

Measure	Time frame
VAS pain score	—

Countries

Korea, Republic of

Contacts

Public Contacthyungjoon kim

The Catholic University of Korea, Seoul St. Mary's Hospital

khjsdsd@gmail.com+82-2-2258-6359

Outcome results